Protocols

PDV specifications

Information


Unique identifier OMICS_27494
Name PDV
Alternative names Proteomic Data Visualization, Proteomic Data Viewer
Software type Application/Script
Interface Graphical user interface
Restrictions to use None
Operating system Unix/Linux, Mac OS, Windows
Programming languages Java, R
License GNU General Public License version 3.0
Computer skills Medium
Version 1.3.0
Stability Stable
Maintained Yes

Download


download.png
github.png

Versioning


No version available

Documentation


Maintainer


  • person_outline Bo Wen

Information


Unique identifier OMICS_27494
Name PDV
Alternative names Proteomic Data Visualization, Proteomic Data Viewer
Interface Web user interface
Restrictions to use None
License GNU General Public License version 3.0
Computer skills Basic
Stability Stable
Maintained Yes

Documentation


Maintainer


  • person_outline Bo Wen

Publication for Proteomic Data Visualization

PDV citation

call_split

Detection of Proteome Diversity Resulted from Alternative Splicing is Limited by Trypsin Cleavage Specificity*

2017
PMCID: 5836368
PMID: 29222161
DOI: 10.1074/mcp.RA117.000155
call_split See protocol

[…] nd converted to proBAM files as described above. A minimum peptide length of 6 was required for all downstream analyses. MS/MS identification results were visualized using the proteomics data viewer (PDV, manuscript under preparation) available at http://pdv.zhang-lab.org, and annotated spectra for all junction peptides are available in supplementary File S2. […]

PDV institution(s)
BGI-Shenzhen, Shenzhen, China; China National GeneBank, BGI-Shenzhen, Shenzhen, China; KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
PDV funding source(s)
Supported by grant U24CA210954 from the National Cancer Institute Clinical Proteomic Tumor Analysis Consortium (CPTAC), by grant CPRIT RR160027 from the Cancer Prevention & Research Institutes of Texas, by funding from the McNair Medical Institute at The Robert and Janice McNair Foundation, and by funding from the National Key R&D Program of China (2017YFC0908400).

PDV reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review PDV